Product: | 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | CN19725 | ||||||||
Synonyms: |
AICAR-13C2,15N; Acadesine-13C2,15N; 5-Amino-4-imidazolecarboxamide Riboside-13C2,15N; Arasine-13C2,15N; GP 1-110-13C2,15N; NSC 105823-13C2,15N |
||||||||
Pricing: |
|
||||||||
Formula: | C713C2H14N315NO5 | ||||||||
Molecular Weight: | 261.21 | ||||||||
Structure: | |||||||||
Category: | Carbohydrates and Derivatives Alphabetic Listing | ||||||||
Literature References: |
Favero, Carlita B.; Mandell, James W., A pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellation. Brain Research, 2007, 1168: 1–10.; Cronstein, BN; Kamen, BA, 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls? Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology, 2007, 29 (12): 805–7. |
||||||||
MSDS: | |||||||||
Applications: | A labeled AMP-activated protein kinase activator. Used to treat acute lymphoblastic leukemia. May be used to treat diabetes. An adenosine regulating agent. |